patient_id	feature_display	tested_subfeature	therapy_name	n_mut	n_wt	n_mut_tested	n_wt_tested	mut_ic50_median	mut_ic50_mean	mut_ic50_std	wt_ic50_median	wt_ic50_mean	wt_ic50_std	pvalue_mww	statistic
MEL-IPI_Pat110	EGFR p.E59* (Nonsense)	EGFR	Afatinib	242	1581	143	662	5.068	12.723	30.49	6.136	19.408	73.149	0.011	53735.5
MEL-IPI_Pat110	EGFR p.E59* (Nonsense)	EGFR Somatic Variant	Afatinib	120	1703	70	735	3.91	12.067	27.67	6.071	18.806	70.212	0.011	30463.5
MEL-IPI_Pat110	EGFR p.E59* (Nonsense)	EGFR Somatic Variant Nonsense	Afatinib	7	1816	4	801	3.142	3.419	0.946	5.942	18.294	67.761	0.182	2222.0
MEL-IPI_Pat110	EGFR p.E59* (Nonsense)	EGFR Somatic Variant Nonsense p.E59*	Afatinib	0	1823	0	805				5.9	18.22	67.6	nan	
MEL-IPI_Pat110	KIT p.N822Y (Missense)	KIT	Imatinib	131	1692	35	372	18.167	20.991	14.549	18.314	21.315	16.18	0.905	6589.5
MEL-IPI_Pat110	KIT p.N822Y (Missense)	KIT Somatic Variant	Imatinib	77	1746	24	383	17.788	19.919	13.952	18.401	21.373	16.163	0.59	4898.0
MEL-IPI_Pat110	KIT p.N822Y (Missense)	KIT Somatic Variant Missense	Imatinib	71	1752	23	384	18.113	20.026	14.256	18.358	21.363	16.143	0.605	4700.0
MEL-IPI_Pat110	KIT p.N822Y (Missense)	KIT Somatic Variant Missense p.N822Y	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MEL-IPI_Pat110	PDGFRA p.K504Q (Missense)	PDGFRA	Imatinib	131	1692	31	376	22.608	25.29	24.218	18.171	20.957	15.16	0.586	5484.5
MEL-IPI_Pat110	PDGFRA p.K504Q (Missense)	PDGFRA Somatic Variant	Imatinib	78	1745	22	385	20.697	25.755	26.894	18.187	21.032	15.196	0.841	4127.0
MEL-IPI_Pat110	PDGFRA p.K504Q (Missense)	PDGFRA Somatic Variant Missense	Imatinib	71	1752	18	389	20.697	22.541	14.868	18.187	21.229	16.097	0.741	3339.0
MEL-IPI_Pat110	PDGFRA p.K504Q (Missense)	PDGFRA Somatic Variant Missense p.K504Q	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MEL-IPI_Pat110	KRAS p.F156L (Missense)	KRAS	KRAS (G12C) Inhibitor-12	295	1528	143	585	85.798	388.837	878.357	75.732	249.538	568.621	0.032	36988.0
MEL-IPI_Pat110	KRAS p.F156L (Missense)	KRAS Somatic Variant	KRAS (G12C) Inhibitor-12	222	1601	113	615	86.231	451.372	974.208	75.732	244.843	556.631	0.013	29657.0
MEL-IPI_Pat110	KRAS p.F156L (Missense)	KRAS Somatic Variant Missense	KRAS (G12C) Inhibitor-12	218	1605	111	617	87.816	459.229	981.233	75.441	244.099	555.88	0.006	28629.0
MEL-IPI_Pat110	KRAS p.F156L (Missense)	KRAS Somatic Variant Missense p.F156L	KRAS (G12C) Inhibitor-12	0	1823	0	728				76.431	276.901	643.034	nan	
MEL-IPI_Pat110	FLT3 p.F621I (Missense)	FLT3	Sunitinib	190	1633	52	346	15.1	46.352	71.421	10.402	33.152	60.495	0.319	8225.0
MEL-IPI_Pat110	FLT3 p.F621I (Missense)	FLT3 Somatic Variant	Sunitinib	78	1745	25	373	6.801	41.337	83.169	10.855	34.444	60.541	0.187	5398.0
MEL-IPI_Pat110	FLT3 p.F621I (Missense)	FLT3 Somatic Variant Missense	Sunitinib	68	1755	20	378	4.73	33.386	83.789	11.104	34.956	60.877	0.031	4864.0
MEL-IPI_Pat110	FLT3 p.F621I (Missense)	FLT3 Somatic Variant Missense p.F621I	Sunitinib	0	1823	0	398				10.692	34.877	62.092	nan	
MEL-IPI_Pat110	FLT3 p.S389L (Missense)	FLT3	Sunitinib	190	1633	52	346	15.1	46.352	71.421	10.402	33.152	60.495	0.319	8225.0
MEL-IPI_Pat110	FLT3 p.S389L (Missense)	FLT3 Somatic Variant	Sunitinib	78	1745	25	373	6.801	41.337	83.169	10.855	34.444	60.541	0.187	5398.0
MEL-IPI_Pat110	FLT3 p.S389L (Missense)	FLT3 Somatic Variant Missense	Sunitinib	68	1755	20	378	4.73	33.386	83.789	11.104	34.956	60.877	0.031	4864.0
MEL-IPI_Pat110	FLT3 p.S389L (Missense)	FLT3 Somatic Variant Missense p.S389L	Sunitinib	0	1823	0	398				10.692	34.877	62.092	nan	
MEL-IPI_Pat110	ATM p.E71K (Missense)	ATM	Olaparib	316	1507	175	587	95.832	178.542	282.047	70.533	159.236	333.831	0.026	45658.0
MEL-IPI_Pat110	ATM p.E71K (Missense)	ATM Somatic Variant	Olaparib	223	1600	116	646	93.804	156.246	195.042	73.428	165.003	340.577	0.202	34682.0
MEL-IPI_Pat110	ATM p.E71K (Missense)	ATM Somatic Variant Missense	Olaparib	158	1665	85	677	91.776	153.512	181.88	74.761	164.945	336.201	0.33	26907.0
MEL-IPI_Pat110	ATM p.E71K (Missense)	ATM Somatic Variant Missense p.E71K	Olaparib	0	1823	0	762				75.933	163.67	322.6	nan	
MEL-IPI_Pat110	AKT1 p.E127K (Missense)	AKT1	MK-2206	118	1705	59	712	24.462	92.919	184.213	18.931	70.13	197.902	0.207	18928.0
MEL-IPI_Pat110	AKT1 p.E127K (Missense)	AKT1 Somatic Variant	MK-2206	29	1794	16	755	17.151	55.465	78.958	19.172	72.222	198.62	0.597	6506.0
MEL-IPI_Pat110	AKT1 p.E127K (Missense)	AKT1 Somatic Variant Missense	MK-2206	25	1798	15	756	14.618	55.691	81.724	19.222	72.195	198.489	0.453	6312.0
MEL-IPI_Pat110	AKT1 p.E127K (Missense)	AKT1 Somatic Variant Missense p.E127K	MK-2206	0	1823	0	771				19.172	71.874	196.869	nan	
MEL-IPI_Pat110	EGFR  (Splice Site)	EGFR	Osimertinib	242	1581	138	614	4.126	9.455	14.253	5.746	11.61	24.66	0.006	48749.0
MEL-IPI_Pat110	EGFR  (Splice Site)	EGFR Somatic Variant	Osimertinib	120	1703	67	685	4.392	9.78	15.814	5.593	11.355	23.708	0.1	25741.0
MEL-IPI_Pat110	EGFR  (Splice Site)	EGFR Somatic Variant Splice Site	Osimertinib	0	1823	0	752				5.522	11.214	23.111	nan	
MEL-IPI_Pat110	BRCA1 p.E914K (Missense)	BRCA1	Olaparib	158	1665	94	668	90.45	192.521	281.117	73.428	159.61	328.001	0.22	28944.0
MEL-IPI_Pat110	BRCA1 p.E914K (Missense)	BRCA1 Somatic Variant	Olaparib	99	1724	57	705	121.094	214.27	319.401	74.675	159.579	322.735	0.083	17323.0
MEL-IPI_Pat110	BRCA1 p.E914K (Missense)	BRCA1 Somatic Variant Missense	Olaparib	79	1744	50	712	128.869	234.74	335.719	73.842	158.679	321.312	0.027	14463.0
MEL-IPI_Pat110	BRCA1 p.E914K (Missense)	BRCA1 Somatic Variant Missense p.E914K	Olaparib	0	1823	0	762				75.933	163.67	322.6	nan	
MEL-IPI_Pat110	PDGFRA  (Splice Site)	PDGFRA	Imatinib	131	1692	31	376	22.608	25.29	24.218	18.171	20.957	15.16	0.586	5484.5
MEL-IPI_Pat110	PDGFRA  (Splice Site)	PDGFRA Somatic Variant	Imatinib	78	1745	22	385	20.697	25.755	26.894	18.187	21.032	15.196	0.841	4127.0
MEL-IPI_Pat110	PDGFRA  (Splice Site)	PDGFRA Somatic Variant Splice Site	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MEL-IPI_Pat110	FLT3  (Splice Site)	FLT3	Sunitinib	190	1633	52	346	15.1	46.352	71.421	10.402	33.152	60.495	0.319	8225.0
MEL-IPI_Pat110	FLT3  (Splice Site)	FLT3 Somatic Variant	Sunitinib	78	1745	25	373	6.801	41.337	83.169	10.855	34.444	60.541	0.187	5398.0
MEL-IPI_Pat110	FLT3  (Splice Site)	FLT3 Somatic Variant Splice Site	Sunitinib	0	1823	0	398				10.692	34.877	62.092	nan	
